Salt, stillness & the breath: the story of halotherapy
Updated · Editorial guide, not medical advice

A salt room can be a beautiful reason to pause. Behind modern dry-salt halotherapy is a longer story of underground environments, airway biology and small studies with encouraging signals. Explore what those findings mean without confusing a calming visit with medical treatment.
A quieter moment in Lisburn
Our nine-seat adult salt room and separate family room make room for a slower pace. Come in comfortable clothes, settle in and breathe normally. No exercise target, no screen to follow: simply time set aside for yourself or the people you came with.
If you are searching for a salt room near Belfast or halotherapy in Northern Ireland, you will find us at 92E Warren Gardens, Lisburn. Contact the team to confirm session length, family age guidance and room arrangements; our booking journey is currently a preview, not a reservation system.
Curiosity, not a cure story
Positive findings deserve a careful reading, not dismissal. The research below separates challenge-test responsiveness from lung function, airway inflammation and lasting disease control. It also distinguishes halogenerator exposure from decorative salt and underground environments.
Asthma + Lung UK warns that inhaled salt can irritate airways and trigger asthma attacks or flare-ups. If you have asthma, COPD or another lung condition, discuss suitability with your clinician first, bring prescribed inhalers and keep your normal care unchanged. Stop if breathing becomes uncomfortable.
The science of feeling better
Salt, stillness & the breath
Salt therapy is a calm, screen-free pause for the breath — and early research on airway sensitivity is genuinely interesting.
- Quiet, unhurried time in a dedicated salt room
- Normal clothes, comfortable seats, nothing to do but breathe
- A shared, separate room for families
Good to know: Salt therapy is not a treatment or cure for asthma or any lung condition, and it never replaces prescribed medication.
How it may work
Your airways have a natural conveyor belt: mucus catches particles, and tiny moving hairs called cilia help carry it away. One proposed explanation for inhaled salt is that it draws water towards airway surfaces, potentially loosening mucus so it is easier to clear. This is a hypothesis for dry-salt halotherapy, not proof that a commercial room produces a clinically useful change in mucociliary clearance. Dry aerosol is also not the same as medically prescribed nebulised saline.
What researchers are exploring
Small randomized studies have found encouraging changes in bronchial responsiveness — how readily airways narrow during a test — and some quality-of-life measures. Those signals deserve attention. They sit alongside unchanged lung-function measures and unresolved questions about dose, lasting effects, disease control and who might benefit. Robust evidence for asthma or COPD treatment is not established.
The story and the research
From underground landscapes to a quiet room
Salt-based spa practices at Wieliczka in Poland were documented in the nineteenth century, including in Feliks Boczkowski’s 1843 book. Later interest in cave and mine environments helped shape speleotherapy: time spent underground in distinctive microclimates. The story is one of curiosity about environment and breathing, not proof that salt miners were immune to respiratory illness.
Four settings, four different questions
An underground salt-mine visit is a place-based experience, not automatically a treatment protocol. Speleotherapy uses cave or mine environments whose temperature, humidity and airborne exposures vary. Modern dry-salt halotherapy uses a halogenerator above ground to disperse fine salt aerosol. A salt-decor room may simply have salt walls, lamps or crystals: decoration alone does not demonstrate an airborne dose. Evidence from one setting cannot be assumed to apply to another.
What research suggests
A 2006 trial in 32 adults found an improvement in bronchial hyperresponsiveness compared with placebo, without improved FEV₁ or peak flow. A later pilot in 55 children reported improved responsiveness in the active group and several quality-of-life measures, without better spirometry or an airway-inflammation marker. These are useful early signals, not evidence of a cure or permission to stop medication.
What remains under investigation
Researchers still need larger, longer trials with clear aerosol dosing, comparable control groups and well-reported adverse effects. Important questions include mucus clearance, symptom changes, durability and suitability across different lung conditions. A later adult study found no effect on eosinophilic inflammation. COPD, skin-condition, infection-prevention and immunity claims cannot be established from the small asthma studies.
What to expect
A quieter rhythm: sit comfortably, breathe normally and enjoy a screen-free pause. Families share their own separate setting with an adult supervising throughout. Ask us to confirm session length, family age guidance and room arrangements before visiting. There is no need to chase a sensation or force deep inhalation; your comfort comes first.
Studies vs. your visit here
In Lisburn, our nine-seat adult room and separate family room offer a dedicated place to pause. Normal clothing, comfortable seating and unhurried time together are the heart of the experience. Research protocols do not establish outcomes for these rooms: aerosol delivery, particle size, concentration and session arrangements need verification. If you have sensitive airways, speak to your clinician first; salt can cause coughing, wheezing or an asthma flare. Keep prescribed care unchanged and stop if breathing feels uncomfortable.
Key research, in brief
Study · May 2006
Adults with asthma: airways became less reactive in a breathing test after two weeks of salt-chamber sessions
Randomized placebo-controlled trial: 32 adults with asthma; two weeks of treatment alongside inhaled corticosteroids
Original source: The effect of salt chamber treatment on bronchial hyperresponsiveness in asthmatics — J. Hedman, T. Hugg, J. Sandell and T. HaahtelaWhat the study found
The between-group change in histamine-challenge bronchial hyperresponsiveness favoured salt-generator treatment (P=0.02). FEV₁ and peak expiratory flow did not improve.
What we still don't know
Small and short; responsiveness during a challenge test is not proof of fewer attacks or sustained disease control. Treatment was an add-on to medication. The publication has an erratum; the corrected challenge measure is PD₁₅FEV₁. Its schedule is not our session recommendation.
Study · 2017
Children with mild asthma: less airway reactivity and better quality-of-life scores in a small pilot trial
Double-blind randomized pilot: 55 children aged 5–13 with mild asthma; 14 sessions over seven weeks
Original source: Halotherapy as asthma treatment in children: A randomized, controlled, prospective pilot study — Ronen Bar-Yoseph, Nir Kugelman, Galit Livnat, Michal Gur, Fahed Hakim, Vered Nir and Lea BenturWhat the study found
The active halogenerator group showed improved bronchial hyperresponsiveness and most quality-of-life questionnaire parameters. Spirometry and fractional exhaled nitric oxide (FeNO) did not improve.
What we still don't know
Selected children with mild asthma not receiving anti-inflammatory treatment; a small, short pilot, not advice to discontinue preventers. The abstract does not establish a quantified between-group effect for every reported outcome. Larger trials and long-term follow-up are needed; these study ages do not set our admission policy.
Review · Cochrane review, 2001
Cochrane review of salt-cave therapy: not enough reliable trials yet to judge
Cochrane systematic review: three controlled trials, 124 children with asthma, of underground speleotherapy
Original source: Speleotherapy for asthma — Sylvia P. Beamon, Albrecht Falkenbach, Grigory Fainburg and Klaus LindeWhat the study found
Some included trials reported short-term improvements, but only one trial was of reasonable methodological quality. The reviewers concluded there was not enough reliable evidence to judge whether speleotherapy helps asthma.
What we still don't know
This review covers cave and mine stays, not modern dry-salt halotherapy rooms, and Cochrane now marks it as outdated. It is a reason to describe salt-room evidence as early and mixed rather than proven.
Study · January 2013
A follow-up trial found no change in airway inflammation markers
Double-blind randomized study: 39 adults using inhaled corticosteroids; low-salt, high-salt and placebo groups
Original source: Salt chamber treatment is ineffective in treating eosinophilic inflammation in asthma — J. Sandell, J. Hedman, K. Saarinen and T. HaahtelaWhat the study found
Treatment did not affect sputum eosinophil or neutrophil counts. The authors concluded that earlier responsiveness findings were probably not explained by reduced eosinophilic inflammation.
What we still don't know
This tests particular inflammation markers over ten sessions, not every possible outcome. It is a reason to avoid claiming that a salt-room visit reduces airway inflammation.
Guidance · Publication/revision date not established
Asthma + Lung UK: evidence is mixed; keep your usual treatment
Patient guidance from a UK respiratory charity — not a trial
Original source: Complementary therapies — Asthma + Lung UKWhat the study found
Explains mixed evidence and the possibility of mucus clearance for some people, while warning that inhaled salt may irritate airways and trigger asthma attacks or flare-ups.
What we still don't know
Talk to a healthcare professional and continue prescribed care. This is practical guidance, not evidence of a clinical benefit at this venue; the older supplied salt-therapy page is no longer available.
Guidance · 8 June 2016
American Lung Association: an interesting idea, not yet enough evidence for guidelines
Patient-information article — not original research
Original source: Promising or Placebo? Halo Salt Therapy: Resurgence of a Salt Cave Spa Treatment — American Lung Association Editorial StaffWhat the study found
Sets out a proposed mucus-thinning mechanism and explains that evidence is insufficient to establish halotherapy treatment guidelines.
What we still don't know
Its historical miner anecdote is not independently verified and is not used as a health fact here. A proposed mechanism cannot establish disease prevention or treatment benefit.
History · 1843
1843: an early account of salt spa traditions at Wieliczka, Poland
Digitised historical book — not modern clinical research
Original source: O Wieliczce pod względem historyi naturalnéj, dziejów i kąpieli — Feliks BoczkowskiWhat the study found
Documents nineteenth-century interest in Wieliczka and salt-based spa practices, providing a historical anchor for the story.
What we still don't know
Does not demonstrate modern halogenerator efficacy or establish that miners avoided respiratory illness. We do not identify this publication as the invention of modern halotherapy.
